Meet the Trialist - INVICTUS.
Event: ESC Congress 2022
Topic: Oral Anticoagulation
Session: Meet the Trialist - INVICTUS
INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation.
Event: ESC Congress 2022
Topic: Oral Anticoagulation
Session: HOT LINE SESSION 5
The global burden of disease of rheumatic heart disease : current estimates.
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Rheumatic heart disease: a global problem
ESC 365 is supported by
